CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share

IPO/OfferingPositive
AI Analysis

Summary

TRexBio, backed by Eli Lilly, completed a $117M US IPO priced at $14 per share. The offering represents a significant capital raise for the biotech company.

Importance:6/10
Sentiment:
0.50
IPObiotechfinancingEli Lilly backed
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 9, 2026 8:43 AM

Read Original